Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48.7M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
22.3M
-
Shares change
-
-5.11M
-
Total reported value, excl. options
-
$24.3M
-
Value change
-
-$5.34M
-
Number of buys
-
31
-
Number of sells
-
-41
-
Price
-
$1.09
Significant Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q2 2025
89 filings reported holding HOWL - Werewolf Therapeutics, Inc. - Common Stock as of Q2 2025.
Werewolf Therapeutics, Inc. - Common Stock (HOWL) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
of 48.7M outstanding shares and own 45.89% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.68M shares), MPM ASSET MANAGEMENT LLC (4.31M shares), MPM BIOIMPACT LLC (2.41M shares), BANK OF AMERICA CORP /DE/ (2.13M shares), VANGUARD GROUP INC (1.3M shares), MILLENNIUM MANAGEMENT LLC (697K shares), SPHERA FUNDS MANAGEMENT LTD. (627K shares), DC Funds, LP (589K shares), PFM Health Sciences, LP (401K shares), and JANE STREET GROUP, LLC (375K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.